Drug: omalizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 175 Number of Pages: 9
DRUGNAME | PT | EventCount | |
---|---|---|---|
Omalizumab | Swelling | 3 | view events |
Omalizumab | Swelling face | 3 | view events |
Omalizumab | Abdominal wall abscess | 2 | view events |
Omalizumab | Abscess | 2 | view events |
Omalizumab | Anaphylactoid reaction | 2 | view events |
Omalizumab | Application site haemorrhage | 2 | view events |
OMALIZUMAB | Arrhythmia supraventricular | 2 | view events |
Omalizumab | Bronchospasm | 2 | view events |
Omalizumab | CD4 lymphocytes decreased | 2 | view events |
Omalizumab | CD8 lymphocytes decreased | 2 | view events |
Omalizumab | Conjunctivitis | 2 | view events |
Omalizumab | Croup infectious | 2 | view events |
Omalizumab | Cryptorchism | 2 | view events |
Omalizumab | Cutis laxa | 2 | view events |
Omalizumab | Dermatitis | 2 | view events |
Omalizumab | Dry skin | 2 | view events |
OMALIZUMAB | Endocarditis fibroplastica | 2 | view events |
OMALIZUMAB | Eosinophilic granulomatosis with polyangiitis | 2 | view events |
Omalizumab | Erythema | 2 | view events |
Omalizumab | Exposure during breast feeding | 2 | view events |
Total Drug/Injury Combinations: 175 Number of Pages: 9
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)